UiPath remains a buy, outperforming the S&P 500 with a 53.6% gain since March 2025, driven by operational turnaround. Click ...

UiPath (NYSE: PATH), a global leader in agentic automation, today announced its UiPath Screen Agent powered by Claude Opus ...

Once thought to be doomed by the AI revolution, robotic process automation specialist UiPath (NYSE: PATH) defied critics in ...

Quick Summary ChatGPT thinks UiPath stock could drift lower over the next 60 days, projecting a move toward roughly $16.20 by ...

UiPath hits an inflection point with stabilizing SaaS, AI roadmap, Maestro platform upsells, top partnerships, and clean ...

MINNEAPOLIS--(BUSINESS WIRE)--Deluxe, a trusted Payments and Data company, today announced it has been named an UiPath AI25 Award Winner. The annual award program identifies the 25 most innovative ...

These high-risk, high-reward stocks could generate huge gains if they can become market leaders in their respective fields.

The Relative Strength (RS) Rating for UiPath PATH entered a new percentile Tuesday, with an increase from 77 to 83. Please ...

Testing an AI agent for donor tissue screening at Evergen surfaces more than technical performance questions. The project ...

Figma went public at $33 last July and currently trades at approximately $37. UiPath went public at $56 in April 2021, but it ...

If you are wondering whether UiPath's share price reflects its true worth or leaves some room on the table, you are in the right place. UiPath's stock closed at US$15.88, with a 5.7% decline over the ...

Payments and data company recognized as one of the 25 most innovative UiPath customers using AI and automation The UiPath AI25 Awards acknowledge customers using AI and automation to supercharge ...